Symbols

PRVA

Privia Health·NASDAQ

--(--)

PRVA fundamentals

PRVA Q4 2025 Earnings

Privia Health (PRVA) released its earnings on Feb 26, 2026: revenue was 541.17M (YoY +17.42%), beat estimates; EPS was 0.07 (YoY +133.33%), beat estimates.

Revenue / YoY

541.17M

+17.42%

EPS / YoY

0.07

+133.33%

Report date

Feb 26, 2026

PRVA Earnings Call Summary for Q4,2025

Revenue & EBITDA Growth: 16.9% practice collections growth to $3.47B, 38.8% EBITDA expansion to $125.5M.
Free Cash Flow Strength: 130% EBITDA conversion in 2025, targeting 80% in 2026 with $600M cash by year-end.
AI & Expansion: Investing in AI across 5 buckets; Arizona IMS partnership driving 15% Medicare Advantage growth.
Strategic Acquisitions: Evolent ACO deal adds 120,000 lives, aligning with 20%+ EBITDA growth target.
Payer Resilience: Diversified book (1.5M attributed lives across 130+ programs) mitigates regulatory risks.

Earnings

EPS

Revenue

Revenue & Expenses

PRVA has released its 2025 Q4 earnings report, with revenue of 541.17M, reflecting a YoY change of 17.42%, and net profit of 10.59M, showing a YoY change of 97.22%. The Sankey diagram below clearly presents PRVA's revenue sources and cost distribution.

Key Indicators

Privia Health (PRVA) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Privia Health (PRVA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Privia Health (PRVA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Privia Health (PRVA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown